There are now many claims linked to allegations involving the Sanofi insulin lawsuit. Patients and families have raised claims that they faced serious medical complications due to insulin price increases, access to insulin medications, and injuries caused by insulin.
Many individuals across the United States are wondering if they can file a claim based on financial distress, dangerous injuries caused by a lack of insulin access, unfair price hikes, or pharmaceutical wrongdoing. Sanofi claims are evolving, and individuals may want to stay informed on eligibility requirements, potential settlements, and filing deadlines.
Sanofi manufactures several types of insulin and insulin medications used to treat diabetes. For quite some time now, the cost of insulin has sparked considerable legal battles and governmental investigations.
Several claims have been made against companies for price-hiking essential diabetes medications to levels that could place them out of reach for some patients. The claims are just a few examples of widespread insulin litigation being filed against manufacturers and pharmacy benefit managers.
Overview of Sanofi Insulin Claims
Insulin medications help people regulate their blood sugar levels when living with diabetes. Numerous claims have alleged that defendants deliberately raised prices on insulin over the years, which could force some patients to ration insulin.
Those claiming they had to ration their insulin due to its cost are bringing forward allegations of facing life-threatening complications because of it. These serious injuries may have occurred after patients waited to refill prescriptions, took lower doses than prescribed, or were allegedly forced to stop taking insulin altogether.
Patients have also alleged that they paid unjustly inflated prices for insulin over time. Some cases have been filed on behalf of individuals who have passed away from diabetes-related complications. Sanofi claims are pending in multiple states, and facts can vary based on the type of harm alleged. Like many pharmaceutical claims, plaintiffs can pursue claims individually or via mass tort litigation if their legal theories and claims are similar.
Because of the widespread concern over this matter, insulin prices have begun to decrease over the last few years. From a peak of $0.33 in 2019, prices gradually decreased to an average of $0.19 per insulin unit in mid-2024. This is the lowest average in 10 years. Additionally, it is a 42% drop from 2019.
Types of Sanofi Insulin Claims
Many individuals facing insulin-related complications have pursued litigation against pharmaceutical companies. While details vary from case to case, common types of Sanofi claims include:
- Financial injury claims based on paying higher prices for insulin
- Claims related to injuries caused by reduced insulin access or affordability
- Cases involving consumers who developed life-threatening complications after rationing insulin medications
In order to know the specifics of your claim and how to file, it is important to hire an insulin litigation lawyer right away.
Compensation Amounts in an Insulin Claim
Sanofi settlement amounts vary depending on the facts of each case. The value of each case is typically influenced by the evidence available to support the claim. Factors that may influence damages in insulin claims include:
- Cost of medical treatment
- Proof of financial loss
- Evidence of long-term harm or injury
- Strength of medical evidence supporting the claim
For some plaintiffs, compensation may be available through negotiated settlements. Other claims may be litigated to trial or used as benchmark cases to guide settlement amounts for future claims. The discovery process and trials in complex pharmaceutical litigation can take years. While people may want to file claims as soon as possible, they usually want to allow adequate time to gather evidence and understand potential settlement values.
The Statute of Limitations
Each state has statutes of limitations that apply to product liability, personal injury, and wrongful death claims. Patients typically have a limited amount of time to file claims from the time of injury or their death.
The clock on these statutes may start on the date of diagnosis, date of injury, or date the patient or family should have known about the connection between the alleged harm and wrongful conduct. Many factors can affect how statutes of limitations are calculated in pharmaceutical litigation.
Patients who lose loved ones to insulin complications may be able to file wrongful death claims. The deadlines that apply to wrongful death cases are often different from the deadlines for personal injury claims.
Why People File These Claims?
Millions of individuals living with diabetes filed Sanofi insulin claims, claiming increased costs contributed to financial burdens or interrupted access to medication. According to these claims, insulin prices spiked while insulin medications have been available for decades. Some patients claim they could no longer afford insulin and were forced to ration medications, delay refills, or miss insulin doses.
When patients with diabetes do not have access to insulin, they may develop life-threatening conditions, including diabetic ketoacidosis, hospitalization, permanent organ damage, or other severe health issues. Several claims against insulin manufacturers also address the long-term financial impact of inflated insulin prices.
This may include accrued medical bills, lost wages, and continuing medical expenses. Patients and families who file claims could receive compensation for medical bills and lost wages. Plaintiffs may also be able to seek accountability from drug manufacturers for alleged practices influencing insulin availability.
Steps to File a Sanofi Insulin Claim
Patients may begin the claim process by collecting records related to their insulin use, medical treatment, and economic damages. This could include documentation of prescriptions, pharmacy receipts, insurance bills, medical records, physician testimony, and evidence showing how the price of insulin increased over time.
Documentation of medical issues may also be required to show how insulin rationing or lack of access to medication allegedly led to other serious health problems. Your attorney may then review the evidence to see if your claim qualifies for any pending insulin litigation or multidistrict litigation.
From there, if a claim is filed, there are many stages of litigation. The claim process may include an investigation, exchange of documents between parties, reviewing professional witnesses, and settlement conferences.
If no settlement can be reached, a claim may go to trial. As with many pharmaceutical claims and product liability claims, these cases can take time because there may be voluminous medical and pricing records for the court to review before reaching a settlement or verdict.
Hire an Insulin Litigation Lawyer
Insulin litigation can be complex and overwhelming. Patients likely have to provide evidence that connects insulin manufacturers to their financial damages and/or medical issues. If you or someone you know has been affected by rising insulin prices or a lack of access to insulin, you should contact an insulin litigation attorney to learn your legal options.
An attorney can help you understand your potential claim options and navigate important filing deadlines. In large-scale claims, patients may benefit from filing their claim as part of multidistrict litigation (MDL). MDLs are court proceedings where cases from across the country are grouped together to streamline the discovery process.
These Sanofi insulin cases allow families to seek compensation for their damages and hold companies accountable for their actions.
FAQs
What Is the Sanofi Controversy?
Sanofi has been involved in controversies surrounding accusations of price gouging on insulin and increasing prices of diabetes drugs in America. Claims state that insulin producers and pharmacy benefit managers colluded to inflate insulin prices year after year. Sanofi has been involved in claims regarding pharmaceutical drugs, drug labeling, and accusations of a lack of transparency with pricing life-saving drugs.
Which Makers of Insulin Are Being Accused of Price Fixing in a Class Action Claim?
Sanofi, Eli Lilly, and Novo Nordisk are among the large insulin producers that have been defendants in claims stating price fixing. Many of these claims have also accused pharmacy benefit managers of artificially inflating the price of insulin through rebate schemes and pricing agreements.
The cases have often claimed that insulin prices increased significantly, though the drugs have been available for decades, and manufacturing them has not substantially increased in cost.
Does Sanofi Have a Good Reputation?
Sanofi is a global pharmaceutical company and one of the largest drug producers in the world. Many of its medications, vaccines, and treatments are sold and used around the world.
As with most big-name pharmaceutical companies, Sanofi has been acknowledged for its advancements in medicine, as well as being subject to litigation and controversy surrounding pricing, product liability claims, and various other regulations. Public opinion is often swayed based on the current controversy or product involved.
What Is the Most Serious Side Effect of Insulin?
One of the most severe side effects of insulin comes when a person experiences serious hypoglycemia. Serious hypoglycemia causes a person’s blood sugar level to drop too low. Warning signs can include confusion, seizures, passing out, or diabetic coma if it gets serious enough. Left untreated, severe hypoglycemia can become life-threatening. Sanofi insulin symptoms can be serious.
Contact Kelley Ferraro, LLC
You or a family member may have legal rights if you faced financial hardship, medical complications, or other losses due to increasing insulin prices. Kelley Ferraro, LLC, works in pharmaceutical litigation and mass tort cases throughout the United States and has worked with many individuals in major injury cases. Schedule your free consultation today to learn more about qualifying criteria, statutes of limitations, and how to file a Sanofi insulin claim. Contact Kelley Ferraro, LLC, today for more information.
